Free Trial
NASDAQ:RDHL

Redhill Biopharma (RDHL) Stock Price, News & Analysis

Redhill Biopharma logo
$2.06 +0.03 (+1.48%)
Closing price 07/7/2025 03:59 PM Eastern
Extended Trading
$2.04 -0.02 (-0.97%)
As of 07/7/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Redhill Biopharma Stock (NASDAQ:RDHL)

Key Stats

Today's Range
$2.01
$2.06
50-Day Range
$1.75
$2.23
52-Week Range
$1.71
$20.28
Volume
12,504 shs
Average Volume
163,432 shs
Market Capitalization
$4.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RDHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Redhill Biopharma and its competitors with MarketBeat's FREE daily newsletter.

RDHL Stock News Headlines

This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
RedHill Biopharma Ltd. (RDHL) - Yahoo Finance
See More Headlines

RDHL Stock Analysis - Frequently Asked Questions

Redhill Biopharma's stock was trading at $6.21 at the start of the year. Since then, RDHL stock has decreased by 66.8% and is now trading at $2.06.

Redhill Biopharma Ltd. (NASDAQ:RDHL) released its earnings results on Tuesday, November, 30th. The biotechnology company reported ($500.00) earnings per share for the quarter, missing the consensus estimate of ($480.00) by $20.00. The biotechnology company had revenue of $21.61 million for the quarter, compared to analyst estimates of $23.41 million.

Redhill Biopharma shares reverse split before market open on Tuesday, August 20th 2024.The 1-25 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of RDHL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Redhill Biopharma investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), Broadcom (AVGO), CymaBay Therapeutics (CBAY) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/30/2021
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RDHL
Previous Symbol
ASX:RDH
Employees
210
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.04 million
Price / Cash Flow
N/A
Book Value
($3.66) per share
Price / Book
-0.56

Miscellaneous

Free Float
2,136,000
Market Cap
$4.72 million
Optionable
No Data
Beta
4.22

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:RDHL) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners